Every day, an estimated 1,650 women worldwide are diagnosed with cervical cancer, and more than half of them die within a year.
In Ghana alone, nearly eight women receive this diagnosis daily, contributing to an annual death toll of about 1,700.
Speaking at a WHO media engagement on the HPV vaccine in Accra, the WHO Representative in Ghana, Dr Fiona Braka, noted that 70% of cases in the country are detected at advanced stages, making treatment costly and overwhelming for families and communities.
Dr Braka explained that persistent HPV infection—the leading cause of cervical cancer—affects more than 80% of sexually active individuals by the age of 45.
However, the HPV vaccine has proven highly effective, with countries like Rwanda already recording significant progress following widespread immunization.
Dr Braka reiterated the global target to eliminate cervical cancer by 2030 through the 90-70-90 strategy, which aims to:
-
Vaccinate 90% of girls by age 15
-
Screen 70% of women at ages 35 and 45
-
Ensure 90% of women with cervical lesions receive timely treatment
She emphasized that HPV vaccination remains the most effective tool for eradicating cervical cancer.
Ghana’s vaccination programme, targeting girls aged 9–14 years, aligns with global best practices and is designed to remove financial barriers, ensuring equitable access for all eligible girls.
Source: Afia Amankwah Tamakloe
READ ALSO:
